Melbourne private equity firm BGH Capital is powering through a turnaround at in-vitro fertilisation clinics player Virtus Health, as it recovers from an earnings slump that swelled leverage levels and landed it on the radar of special situations players.
Virtus Health has used AI software to assist embryologists rank embryos.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com
